BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

35 related articles for article (PubMed ID: 15574789)

  • 21. The X-linked inhibitor of apoptosis protein (XIAP) is up-regulated in metastatic melanoma, and XIAP cleavage by Phenoxodiol is associated with Carboplatin sensitization.
    Kluger HM; McCarthy MM; Alvero AB; Sznol M; Ariyan S; Camp RL; Rimm DL; Mor G
    J Transl Med; 2007 Jan; 5():6. PubMed ID: 17257402
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of tumor necrosis factor--related apoptosis-inducing ligand receptors 1 and 2 in melanoma.
    McCarthy MM; DiVito KA; Sznol M; Kovacs D; Halaban R; Berger AJ; Flaherty KT; Camp RL; Lazova R; Rimm DL; Kluger HM
    Clin Cancer Res; 2006 Jun; 12(12):3856-63. PubMed ID: 16778114
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HDM2 protein overexpression, but not gene amplification, is related to tumorigenesis of cutaneous melanoma.
    Polsky D; Bastian BC; Hazan C; Melzer K; Pack J; Houghton A; Busam K; Cordon-Cardo C; Osman I
    Cancer Res; 2001 Oct; 61(20):7642-6. PubMed ID: 11606406
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Automated quantitative analysis of tissue microarrays reveals an association between high Bcl-2 expression and improved outcome in melanoma.
    Divito KA; Berger AJ; Camp RL; Dolled-Filhart M; Rimm DL; Kluger HM
    Cancer Res; 2004 Dec; 64(23):8773-7. PubMed ID: 15574790
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Melanoma biomarker expression in melanocytic tumor progression: a tissue microarray study.
    Nazarian RM; Prieto VG; Elder DE; Duncan LM
    J Cutan Pathol; 2010 Apr; 37 Suppl 1():41-7. PubMed ID: 20482674
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation of histopathologic characteristics to protein expression and function in malignant melanoma.
    Welinder C; Pawłowski K; Szasz AM; Yakovleva M; Sugihara Y; Malm J; Jönsson G; Ingvar C; Lundgren L; Baldetorp B; Olsson H; Rezeli M; Laurell T; Wieslander E; Marko-Varga G
    PLoS One; 2017; 12(4):e0176167. PubMed ID: 28445515
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of the ets-1 proto-oncogene in melanocytic lesions.
    Keehn CA; Smoller BR; Morgan MB
    Mod Pathol; 2003 Aug; 16(8):772-7. PubMed ID: 12920221
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Automated quantitative analysis of HDM2 expression in malignant melanoma shows association with early-stage disease and improved outcome.
    Berger AJ; Camp RL; Divito KA; Kluger HM; Halaban R; Rimm DL
    Cancer Res; 2004 Dec; 64(23):8767-72. PubMed ID: 15574789
    [TBL] [Abstract][Full Text] [Related]  

  • 29.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 30.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 31.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 32.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.